Live news related to DBV TECHNOLOGIES stock (FR0010417345): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The French biotech company falls midday, bucking the trend of a well-oriented SBF 120. The stock breaks a closely watched technical threshold downward…
The French biotech company sees a significant midday decline in a mostly stable SBF 120 market. The stock approaches a closely watched technical thres…
The French biotech is losing ground in a downward trending Parisian market. The stock has fallen below its short-term moving averages after a recent, …
DBV Technologies stock moves forward in mid-session in a well-oriented Parisian market. However, the French biotech remains down for the week and belo…
DBV Technologies shares gained 1.78% to €3.44 in mid-afternoon trading, within an SBF 120 index up by 0.84%. The French biotech's stock partially reco…
DBV Technologies' stock falls by 2.01% to €3.41 in early afternoon trading, within a nearly stable SBF 120 (-0.13%). The French biotech ranks 118th in…
French biotech company advances 2.85% to €3.54 in mid-morning trading, alongside a 1.58% increase in the CAC 40. The stock is trading close to its 50-…
The stock of the French biotech company increased by 2.2% to €3.43 mid-session in a rising Parisian market. The previous day, Kempen maintained its bu…
The stock of the French biotech company declined sharply during the session to €3.36, following the announcement of its first quarter 2026 results las…
DBV Technologies unveils its regulatory submission schedule for its flagship pediatric allergy treatment. The French biotech plans two biologics licen…
